STIMIT Company

STIMIT enables extended local delivery of cancer immunotherapy in the context of tumor resection.

Investors

Industry: Regenerative medicine
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 1/1/2018
Employees Number: 1-10
Total Funding: 20634443
Last Funding Type: Venture - Series Unknown

Visit Website
info@stimittx.com
Register and Claim Ownership